Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04298151Phase 2Completed
Phase 2, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Clinical performance of Glass Ionomer restorations at 1 year. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04298151.